Dickmeyer Boyce Financial Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.98M Sell
15,232
-151
-1% -$38.7K 2.04% 12
2026
Q2
$3.87M Sell
15,383
-301
-2% -$64.8K 2.01% 11
2026
Q1
$3.41M Buy
+15,684
New +$3.48M 2.01% 12

Other funds holding ABBV

Dickmeyer Boyce Financial Management's ABBV Position: Q3 2026 in Review

Dickmeyer Boyce Financial Management reduced its AbbVie (ABBV) stake by 0.98% in Q3 2026, selling an estimated $38.7K and leaving 15,232 shares worth $3.98M. The position accounts for 2.04% of the portfolio, ranked #12.

Dickmeyer Boyce Financial Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. 165 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Dickmeyer Boyce Financial Management held 15,232 shares of AbbVie worth $3.98M as of Q3 2026.
  • Dickmeyer Boyce Financial Management sold 151 AbbVie shares in Q3 2026, an estimated $38.7K.
  • AbbVie made up 2.04% of Dickmeyer Boyce Financial Management's portfolio in Q3 2026, its #12 holding.
  • Dickmeyer Boyce Financial Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
  • 165 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Dickmeyer Boyce Financial Management's 13F filing for Q3 2026, filed 8 Oct 2026.